Xcout Intel
Seer, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Seer, Inc. among biotech companies — ranked by similarity to what Seer, Inc. actually does, not by market-cap band.
Subscribe to see Seer, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Seer, Inc.
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
Seer, Inc. at a glance
Seer, Inc. is a biotech company headquartered in Redwood City, United States. It is publicly listed (SEER) with a market capitalisation of $111.9M. Xcout tracks 20 named people at Seer, Inc., including Omid Farokhzad (Chair and Chief Executive Officer). Xcout recorded 9 job postings from Seer, Inc. in the last 90 days.
Seer, Inc. leadership
- Omid FarokhzadChair and Chief Executive Officer
- David R. HornPresident,Treasurer & Chief Financial Officer
- Anthony BazarkoChief Commercial Officer
- Kenny RossChief Operations & Product Officer
- Marissa DixonChief People Officer
- Serafim BatzoglouChief Data Officer
14 more named people on record for Seer, Inc., with roles, board committees and tenure — see the full roster →
Seer, Inc. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $55M | 1 named |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Seer, Inc.
Xcout recorded 9 job postings from Seer, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Seer, Inc.'s hiring signals →
Top 12 Seer, Inc. competitors
Ranked by semantic similarity — how close each company is to Seer, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Glyphic Biotechnologies is a biotechnology research company headquartered in Berkeley, California, dedicated to next-generation proteome sequencing and rewriting the rules of proteomics.
Biotechnology
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Biotechnology
Olink Proteomics provides high-throughput protein biomarker analysis products, instruments, software, and analysis services for life science research and drug development. Utilizing its proprietary Proximity Extension Assay (PEA) technology and next-generation sequencing, the company serves researchers and pharmaceutical organizations focused on biomarker discovery and precision medicine.
Similar biotech company
Pixelgen Technologies is a Swedish life-sciences company developing spatial proteomics technology that maps the location and interactions of proteins in and around individual cells. Its tools are intended for academic, biopharmaceutical, and biomedical researchers studying cell biology, immunology, and disease mechanisms.
Similar biotech company
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Similar biotech company
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Similar biotech company
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Similar biotech company
Proteona is a Singapore-based biotechnology company that develops single-cell multi-omics and AI-based analytics technologies for profiling immune cells and other biological systems. It serves biopharmaceutical companies and research organizations involved in drug discovery, development, and precision medicine.
Biotechnology
Phase Genomics, Inc. is headquartered in Seattle, Washington, and provides ultra-long-range sequencing solutions and Hi-C technologies. The company supports genomic research and applications through its specialized laboratory products and services.
Life Sciences, Diagnostics
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
Biotechnology
Pacific Biosciences of California, Inc. is a global life sciences technology company headquartered in Menlo Park, California, that develops genetic sequencing systems.
Biotechnology
Arima Genomics is a biotechnology company headquartered in San Diego, California. The company leverages whole-genome sequence and three-dimensional genomic structure information to advance life science research and cancer therapy.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Seer, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Seer, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →